Adial Pharmaceuticals (Adial Pharmaceuticals) Current Accrued Expense : $0.19 Mil (As of Mar. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Adial Pharmaceuticals Current Accrued Expense?

Adial Pharmaceuticals's Current Accrued Expense for the quarter that ended in Mar. 2024 was $0.19 Mil.

Adial Pharmaceuticals's quarterly Current Accrued Expense increased from Sep. 2023 ($0.08 Mil) to Dec. 2023 ($0.11 Mil) and increased from Dec. 2023 ($0.11 Mil) to Mar. 2024 ($0.19 Mil).

Adial Pharmaceuticals's annual Current Accrued Expense declined from Dec. 2021 ($1.86 Mil) to Dec. 2022 ($0.38 Mil) and declined from Dec. 2022 ($0.38 Mil) to Dec. 2023 ($0.11 Mil).

Adial Pharmaceuticals Current Accrued Expense Historical Data

The historical data trend for Adial Pharmaceuticals's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Adial Pharmaceuticals Current Accrued Expense Chart

Adial Pharmaceuticals Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Current Accrued Expense

Get a 7-Day Free Trial

0.09

0.53

1.86

0.38

0.11

Adial Pharmaceuticals Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Current Accrued Expense	Get a 7-Day Free Trial															0.11	0.07	0.08	0.11	0.19

Adial Pharmaceuticals Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.

Adial Pharmaceuticals Current Accrued Expense Related Terms

Thank you for viewing the detailed overview of Adial Pharmaceuticals's Current Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Adial Pharmaceuticals (Adial Pharmaceuticals) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Adial Pharmaceuticals Inc (NAS:ADILW) » Definitions » Current Accrued Expense

Comparable Companies

Traded in Other Exchanges

ADIL:USA

Address

1180 Seminole Trail, Suite 495, Charlottesville, VA, USA, 22901

Website

https://www.adialpharma.com

Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company develops prescription medications for addiction and related disorders. Its lead product is AD04, which is for the treatment of alcohol use disorder.